Status:
UNKNOWN
Soft Tissue Tenderness and Fibromyalgia Among Schizophrenia Patients.
Lead Sponsor:
HaEmek Medical Center, Israel
Conditions:
Fibromyalgia
Schizophrenia
Eligibility:
All Genders
18+ years
Brief Summary
Numerous studies reported on comorbidity of fibromyalgia and psychiatric disorders. Approximately 30% of patients with fibromyalgia have major depression at the time of diagnosis; the lifetime prevale...
Eligibility Criteria
Inclusion
- Women above 18 years of age.
- Patients must meet DSM-5 criteria for a diagnosis of schizophrenia.
- A stabled mental state.
- If hospitalized, patients are scheduled for discharge on the basis of clinical assessment of psychiatric symptoms.
Exclusion
- Mental co-morbidity.
- Diagnosis of myofascial pain syndrome or chronic fatigue syndrome.
- Alcohol or drug use.
- Usage of any pain reliever medications during the week before recruitment.
Key Trial Info
Start Date :
June 10 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 10 2024
Estimated Enrollment :
286 Patients enrolled
Trial Details
Trial ID
NCT05328518
Start Date
June 10 2021
End Date
September 10 2024
Last Update
April 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Haemek medical center
Afula, Israel, 1910500